13 studies found for:    RHEUMATOID ARTHRITIS, SYSTEMIC JUVENILE
Show Display Options
RSS Create an RSS feed from your search for:
RHEUMATOID ARTHRITIS, SYSTEMIC JUVENILE
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Safety and Effectiveness of Rilonacept for Treating Systemic Juvenile Idiopathic Arthritis in Children and Young Adults
Condition: Juvenile Idiopathic Arthritis
Intervention: Biological: Rilonacept
2 Completed Ultrasonography in Juvenile Idiopathic Arthritis
Conditions: Juvenile Idiopathic Arthritis, Oligoarthritis;   Polyarticular Juvenile Rheumatoid Arthritis;   Systemic Juvenile Idiopathic Arthritis
Intervention: Device: Ultrasonography
3 Recruiting A Study of RoActemra/Actemra (Tocilizumab) in Patients Less Than 2 Years Old With Active Systemic Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis, Rheumatoid Arthritis
Intervention: Drug: Tocilizumab [RoActemra/Actemra]
4 Unknown  Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune Diseases
Conditions: Purpura, Schoenlein-Henoch;   Graft Versus Host Disease;   Anemia, Hemolytic, Autoimmune;   Rheumatoid Arthritis;   Churg-Strauss Syndrome;   Hypersensitivity Vasculitis;   Wegener's Granulomatosis;   Systemic Lupus Erythematosus;   Giant Cell Arteritis;   Pure Red Cell Aplasia;   Juvenile Rheumatoid Arthritis;   Polyarteritis Nodosa;   Autoimmune Thrombocytopenic Purpura;   Takayasu Arteritis
Interventions: Drug: anti-thymocyte globulin;   Drug: cyclophosphamide;   Drug: cyclosporine;   Drug: filgrastim;   Drug: methylprednisolone;   Drug: prednisone;   Procedure: Autologous Peripheral Blood Stem Cell Transplantation
5 Terminated Safety and Efficacy Study of Etanercept (Enbrel®) In Children With Systemic Onset Juvenile Rheumatoid Arthritis
Condition: Juvenile Rheumatoid Arthritis
Interventions: Drug: Enbrel;   Drug: Placebo
6 Completed Pilot Study of Total Body Irradiation in Combination With Cyclophosphamide, Anti-thymocyte Globulin, and Autologous CD34-Selected Peripheral Blood Stem Cell Transplantation in Children With Refractory Autoimmune Disorders
Conditions: Systemic Sclerosis;   Systemic Lupus Erythematosus;   Dermatomyositis;   Juvenile Rheumatoid Arthritis;   Autoimmune Diseases
Intervention: Procedure: Stem Cell Transplantation
7 Unknown  Safety and Efficacy of Anti-Pandemic H1N1 Vaccination in Rheumatic Diseases
Conditions: Rheumatoid Arthritis;   Spondyloarthritis;   Systemic Lupus Erythematosus (SLE);   Dermatomyositis (DM);   DMixed Connective Tissue Disease;   Systemic Vasculitis;   Systemic Sclerosis (SSc);   Sjögren's Syndrome;   Antiphospholipid Syndrome;   Juvenile Idiopathic Arthritis;   Juvenile SLE;   Juvenile DM
Intervention: Biological: Anti-pandemic H1N1 influenza vaccine
8 Completed Safety, Efficacy and Pharmacokinetics of Subcutaneous ACZ885 in Patients With Systemic Juvenile Idiopathic Arthritis (SJIA)
Condition: Arthritis, Juvenile Rheumatoid
Intervention: Drug: ACZ885
9 Completed
Has Results
Flare Prevention Study of Canakinumab in Patients With Active Systemic Juvenile Idiopathic Arthritis (SJIA)
Condition: Systemic Juvenile Idiopathic Arthritis With Active Flare
Interventions: Drug: canakinumab;   Drug: placebo
10 Terminated
Has Results
Single-dose Study to Assess Efficacy of Canakinumab (ACZ885) in Patients With Active Juvenile Idiopathic Arthritis (SJIA)
Condition: Systemic Juvenile Idiopathic Arthritis
Interventions: Drug: Canakinumab;   Drug: Placebo
11 Terminated Single Patient Use of Tocilizumab in Systemic Onset Juvenile Idiopathic Arthritis
Conditions: Arthritis, Juvenile Rheumatoid;   Still's Disease, Juvenile Onset
Intervention: Biological: tocilizumab
12 Unknown  Alendronate Osteoporosis Study
Condition: Glucocorticoid-Associated Osteopenia and Osteoporosis
Intervention: Drug: Alendronate
13 Recruiting Glycosylated Ferritin in Macrophagic Activation Syndromes
Conditions: Still's Disease, Adult-Onset;   Sepsis;   Macrophagic Activation Syndrome
Intervention:

Indicates status has not been verified in more than two years